EPLAW PATENT BLOG

FR – France Brevets and Ms W. v. Nintendo

Posted: September 1st, 2016

France Brevets fails in its attempt to get more than €80,000,000 from Nintendo in Wii Balance Board-related patent dispute as a result of file wrapper estoppel Ms W. and France Brevets v. Nintendo France and Nintendo of Europe, judgment of the tribunal de grande instance de Paris dated 26 May 2016, docket № 14/05090, with […]

READ MORE

UK – Napp v. Dr Reddy’s / Sandoz

Posted: August 3rd, 2016

Napp Pharmaceutical Holdings Limited v (1) Dr Reddy’s Laboratories (UK) Limited (2) Sandoz Limited. UK Patents Court (Arnold J). Case neutral citation number: [2016] EWHC 1517 (Pat) In a decision that considers both numerical ranges and de minimis patent infringement, the UK Patents Court has held that products (7 day buprenorphine transdermal patches) proposed to […]

READ MORE

NL – Tata Steel v. Arcelormittal

Posted: July 30th, 2016

Tata Steel IJmuiden B.V. v. Arcelormittal France, District Court The Hague, 20 July 2016, Case No. ECLI:NL:RBDHA:2016:8116 Tata Steel has a legitimate interest in a negative declaratory judgment -even if there is no specific product yet- in view of the huge investments it is about to make. Art. 7(2) EEX Regulation II applies also to […]

READ MORE

NL – JP Russel v. Innovet

Posted: April 8th, 2016

JP Russel Science Ltd. v. Innovet Italia S.r.l., District Court of The Hague, the Netherlands, 30 March 2016, Case number 481573 / HA ZA 15-111 JP Russel develops and markets nutricial supplements and dietetics for medical use. One of the products sold by JP Russel on the Dutch market is PEAPURE, a product that includes […]

READ MORE

UK – Bapco v. Selpac

Posted: March 31st, 2016

(1) Bapco Closures Research Limited (2) Aptargroup, Inc. and Aptargroup Inc. v Selpac Europe Limited, High Court of England and Wales, Intellectual Property Enterprise Court (Douglas Campbell QC Deputy Judge) 18 March 2016, neutral citation No. [2016] EWHC 550 (IPEC). The specialist Intellectual Property Enterprise Court (IPEC) in London had to consider whether a word […]

READ MORE

FR – Warner-Lambert Company and Pfizer v. Sandoz

Posted: March 30th, 2016

Lyrica® in France: Pfizer fails in preliminary injunction proceedings based on EP 0 934 061 covering a second medical use of pregabalin for pain Warner-Lambert Company & Pfizer v. Sandoz, order of the presiding judge of the tribunal de grande instance de Paris of 26 October 2015, Docket № 15/58725, with thanks to Pierre Véron, […]

READ MORE

GR – Novartis AG & Novartis Hellas SA v. WELDING GmbH & Co KG

Posted: March 30th, 2016

Novartis AG & Novartis Hellas SA v. WELDING GmbH & Co KG, Greece , First Instance Court of Athens (temporary relief proceedings), Judgment No. 295/2016 The applicants claim that the respondent put in the Greek market generic pharmaceutical products under the mark RIVASTIGMINE/WELDING in the form of transdermal plaster, subject to a dosage scheme falling […]

READ MORE

NL – AstraZeneca v. Resolution

Posted: March 9th, 2016

Astrazeneca and Shionogi v Resolution, Court of Appeal the Hague, the Netherlands, 16 February 2016, Case no. 200.174.337/01, with thanks to Willem Hoyng, Jeroen den Hartog en Judith Krens, HOYNG ROKH MONEGIER, for sending in the judgment and translation in English Scope of protection. The patent (SPC) in suit relates to a new active substanse […]

READ MORE

UK – Regeneron v. Kymab and Novo Nordisk

Posted: February 16th, 2016

Regeneron Pharmaceuticals Inc v Kymab Limited and Novo Nordisk A/S, High Court of England and Wales (Carr J), London, UK, 1 February 2016, Neutral Citation Number: [2016] EWHC 87 (Pat).  On 3 February 2016 the Patents Court (Carr J) held that the disputed claims of two of Regeneron’s patents relating to transgenic mice used for […]

READ MORE